These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33623132)

  • 1. Scenario analysis for programmatic tuberculosis control in Bangladesh: a mathematical modelling study.
    Kuddus MA; Meehan MT; Sayem MA; McBryde ES
    Sci Rep; 2021 Feb; 11(1):4354. PubMed ID: 33623132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling drug-resistant tuberculosis amplification rates and intervention strategies in Bangladesh.
    Kuddus MA; Meehan MT; White LJ; McBryde ES; Adekunle AI
    PLoS One; 2020; 15(7):e0236112. PubMed ID: 32702052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical analysis of a two-strain tuberculosis model in Bangladesh.
    Kuddus MA; McBryde ES; Adekunle AI; White LJ; Meehan MT
    Sci Rep; 2022 Mar; 12(1):3634. PubMed ID: 35256670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scenario Analysis for Programmatic Tuberculosis Control in Western Province, Papua New Guinea.
    Trauer JM; Denholm JT; Waseem S; Ragonnet R; McBryde ES
    Am J Epidemiol; 2016 Jun; 183(12):1138-48. PubMed ID: 27199387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the impact of control strategies on the tuberculosis burden in South and North Korea using a mathematical model.
    Cho H; Park Y; Seok J; Yeom JS; Choi JY; Kim HJ; Kang YA; Lee J
    BMJ Glob Health; 2021 Oct; 6(10):. PubMed ID: 34620614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of tuberculosis burden in China using a dynamic disease simulation model.
    Mehra M; Cossrow N; Kambili C; Underwood R; Makkar R; Potluri R
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1186-94. PubMed ID: 23827732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Disability-Adjusted Life Years (DALYs) and Economic Burden on People With Drug-Susceptible Tuberculosis and Multidrug-Resistant Tuberculosis in Korea.
    Lee S; Kim MJ; Lee SH; Kim HY; Kim HS; Oh IH
    Front Public Health; 2022; 10():848370. PubMed ID: 35480575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategic investment in tuberculosis control in the Republic of Bulgaria.
    Doan TN; Varleva T; Zamfirova M; Tyufekchieva M; Keshelava A; Hristov K; Yaneva A; Gadzheva B; Zhang S; Irbe S; Ragonnet R; McBryde ES; Trauer JM
    Epidemiol Infect; 2019 Nov; 147():e304. PubMed ID: 31736454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation.
    Menzies NA; Cohen T; Lin HH; Murray M; Salomon JA
    PLoS Med; 2012; 9(11):e1001347. PubMed ID: 23185139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Strategies For Tuberculosis to Achieve the Goals of WHO in China: A Seasonal Age-Structured Model Study.
    Xue L; Jing S; Wang H
    Bull Math Biol; 2022 Apr; 84(6):61. PubMed ID: 35486232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracic Radiography Characteristics of Drug Sensitive Tuberculosis and Multi Drug Resistant Tuberculosis: A Study of Indonesian National Tuberculosis Prevalence Survey.
    Sulistijawati RS; Icksan AG; Lolong DB; Nurwidya F
    Acta Medica (Hradec Kralove); 2019; 62(1):24-29. PubMed ID: 30931893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains.
    McBryde ES; Meehan MT; Doan TN; Ragonnet R; Marais BJ; Guernier V; Trauer JM
    Int J Infect Dis; 2017 Mar; 56():14-20. PubMed ID: 28163165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
    Laurence YV; Griffiths UK; Vassall A
    Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-Pacific.
    Trauer JM; Denholm JT; McBryde ES
    J Theor Biol; 2014 Oct; 358():74-84. PubMed ID: 24878110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of active case finding on transmission dynamics of tuberculosis: A modelling study.
    Ayabina DV; Gomes MGM; Nguyen NV; Vo L; Shreshta S; Thapa A; Codlin AJ; Mishra G; Caws M
    PLoS One; 2021; 16(11):e0257242. PubMed ID: 34797864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategic priorities for TB control in Bangladesh, Indonesia, and the Philippines - comparative analysis of national TB prevalence surveys.
    Kak N; Chakraborty K; Sadaphal S; AlMossawi HJ; Calnan M; Vikarunnessa B
    BMC Public Health; 2020 Apr; 20(1):560. PubMed ID: 32334545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the yield of tuberculosis among contacts of multidrug-resistant and drug-sensitive tuberculosis patients in Ethiopia using GeneXpert as a primary diagnostic test.
    Hiruy N; Melese M; Habte D; Jerene D; Gashu Z; Alem G; Jemal I; Tessema B; Belayneh B; Suarez PG
    Int J Infect Dis; 2018 Jun; 71():4-8. PubMed ID: 29559367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of treating multidrug-resistant tuberculosis.
    Resch SC; Salomon JA; Murray M; Weinstein MC
    PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.